Mehmet Nuri Özbek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mehmet Nuri Özbek has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Edip Unal
Department of Pediatric Endocrinology, Faculty of Medicine Dicle University Diyarbakır Turkey
15 shared publications - Meliha Demiral
Gazi Yaşargil Training and Research Hospital, Clinic of Pediatric Endocrinology, Diyarbakır, Turkey
12 shared publications - Huseyin Demirbilek
Department of Paediatric Endocrine, Hacettepe University Faculty of Medicine, Ankara, Turkey
8 shared publications - Ruken Yıldırım
Department of Pediatric Endocrinology Diyarbakır Children's Hospital Diyarbakır Turkey
7 shared publications - Özhan Orhan
Department of Pediatrics, Faculty of Medicine Mardin Artuklu University Mardin Turkey
7 shared publications - Şervan Özalkak
Department of Pediatric Endocrinology, Diyarbakır Children’s Hospital, 21100 Diyarbakır, Türkiye
6 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 20 (5) , 1-7
Factors affecting mortality in patients during postoperative follow-up after cardiac surgery in a pediatric intensive care unit
Objective: Congenital heart diseases (CHD) frequently necessitate cardiovascular surgery (CVS) in pediatric patients. This study aimed to evaluate postoperative complications following CVS and to investigate their association with mortality. Materials and Methods: In this retrospective study, the medical records of 124 patients who underwent CVS and were subsequently monitored in the pediatric intensive care unit were reviewed. Results: Among the 124 patients who underwent cardiovascular surgery, 52.4% (n=65) were male. The median age was 7 months (range, 2–71). Ventricular septal defect closure (n=49) and complete atrioventricular septal defect repair (n=15) were the most frequently performed procedures. Twenty-seven patients had chromosomal anomalies, most commonly Down syndrome. No postoperative complications were observed in 95 patients. The most common complications were atelectasis, arrhythmia, and subcutaneous emphysema. Extracorporeal therapy was administered to 12 patients. Overall mortality was 8.8% (n=11). Preoperative pulmonary hypertension (PHT) was the most common cause of death. Among the deceased patients, additional factors associated with mortality include infection and lower albumin levels, while nitric oxide therapy and intraoperative cardiopulmonary bypass use were also more common, possibly reflecting greater clinical severity. Conclusion: As the use of cardiovascular surgery for CHD continues to increase in pediatric patients, optimizing intraoperative management and promptly identifying postoperative complications are crucial for improving survival outcomes.
- 22 May 2026
- Published by Ankara Bilkent City Hospital in Turkish Journal of Pediatric Disease
- Vol. 20 (5) , 1-7
Open AccessFactors affecting mortality in patients during postoperative follow-up after cardiac surgery in a pediatric intensive care unit
Objective: Congenital heart diseases (CHD) frequently necessitate cardiovascular surgery (CVS) in pediatric patients. This study aimed to evaluate postoperative complications following CVS and to investigate their association with mortality. Materials and Methods: In this retrospective study, the medical records of 124 patients who underwent CVS and were subsequently monitored in the pediatric intensive care unit were reviewed. Results: Among the 124 patients who underwent cardiovascular surgery, 52.4% (n=65) were male. The median age was 7 months (range, 2–71). Ventricular septal defect closure (n=49) and complete atrioventricular septal defect repair (n=15) were the most frequently performed procedures. Twenty-seven patients had chromosomal anomalies, most commonly Down syndrome. No postoperative complications were observed in 95 patients. The most common complications were atelectasis, arrhythmia, and subcutaneous emphysema. Extracorporeal therapy was administered to 12 patients. Overall mortality was 8.8% (n=11). Preoperative pulmonary hypertension (PHT) was the most common cause of death. Among the deceased patients, additional factors associated with mortality include infection and lower albumin levels, while nitric oxide therapy and intraoperative cardiopulmonary bypass use were also more common, possibly reflecting greater clinical severity. Conclusion: As the use of cardiovascular surgery for CHD continues to increase in pediatric patients, optimizing intraoperative management and promptly identifying postoperative complications are crucial for improving survival outcomes.
- Open Access
- 22 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (1) , 48-53
Final Height in Patients with Turner Syndrome Treated With Growth Hormone Therapy
Objective: Turner syndrome (TS) is the most common sex chromosome abnormality in girls. Short stature is the most distinctive feature. This study aimed to evaluate factors affecting final height (FH) in patients with TS who received growth hormone (GH) therapy and achieved their final height (FH). Materials and Methods: About 48 patients with TS who received GH therapy and reached their FH were included and examined retrospectively. Initial height, standard deviation score (SDS), FH, and FH SDS measurements of the patients were obtained. Additionally, factors affecting FH were analyzed. Results: Growth hormone was administered at a dose of 45.6 ± 6.2 (min-max: 34-69) μg/kg/day at a mean age of 11.7 ± 2.9 years. The duration of therapy was 4.3 ± 1.4 years. The mean FH of the patients was 147.80 ± 5.98 cm. About 29.2% (n=14) of the patients reached a height above the thirdpercentile. It was observed that GH therapy was initiated in these patients at a mean age of 10.3 ± 3.1 years; the initial height SDS was better. FH of 45,X and non-45,X cases were similar. Conclusion: In the study, GH therapy that was initiated at an early age in patients with good initial height SDS increased the gain of FH and FH SDS. Therefore, initiating GH therapy at an early age in patients with TS is important for height gain. ∆ Height SDS was better in cases that underwent late pubertal induction. Karyotype did not have a predictive effect on height prognosis.
- 22 December 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 61 (1) , 48-53
Open AccessFinal Height in Patients with Turner Syndrome Treated With Growth Hormone Therapy
Objective: Turner syndrome (TS) is the most common sex chromosome abnormality in girls. Short stature is the most distinctive feature. This study aimed to evaluate factors affecting final height (FH) in patients with TS who received growth hormone (GH) therapy and achieved their final height (FH). Materials and Methods: About 48 patients with TS who received GH therapy and reached their FH were included and examined retrospectively. Initial height, standard deviation score (SDS), FH, and FH SDS measurements of the patients were obtained. Additionally, factors affecting FH were analyzed. Results: Growth hormone was administered at a dose of 45.6 ± 6.2 (min-max: 34-69) μg/kg/day at a mean age of 11.7 ± 2.9 years. The duration of therapy was 4.3 ± 1.4 years. The mean FH of the patients was 147.80 ± 5.98 cm. About 29.2% (n=14) of the patients reached a height above the thirdpercentile. It was observed that GH therapy was initiated in these patients at a mean age of 10.3 ± 3.1 years; the initial height SDS was better. FH of 45,X and non-45,X cases were similar. Conclusion: In the study, GH therapy that was initiated at an early age in patients with good initial height SDS increased the gain of FH and FH SDS. Therefore, initiating GH therapy at an early age in patients with TS is important for height gain. ∆ Height SDS was better in cases that underwent late pubertal induction. Karyotype did not have a predictive effect on height prognosis.
- 13 September 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (4) , 1561-1568
Is Fabry disease more prevalent than we think? Understanding the critical role of family screening can make all the difference
- 13 September 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (4) , 1561-1568
Is Fabry disease more prevalent than we think? Understanding the critical role of family screening can make all the difference
- Open Access
- 26 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1579
Evaluation of Children and Adolescents with Thalassemia Major in Terms of Osteoporosis: A Single-Centre Experience
Background/Objectives: This study aimed to determine the frequency of osteoporosis in children and adolescents with thalassemia major (TM) and to identify risk factors for the early development of osteoporosis. Methods: This retrospective study included 27 patients under 18 years of age receiving regular blood transfusions and chelation therapy for TM at our hospital. Bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry, and a lumbar spine Z-score <−2 was considered osteoporotic. Patients with osteoporosis were classified as Group 1 and those without osteoporosis as Group 2. Results: Osteoporosis was detected in 22.2% of the study population. The mean age was 13.83 ± 2.85 years in Group 1 and 7.95 ± 5.05 years in Group 2 (p = 0.012). Body weight and height were significantly lower in Group 1 (p = 0.012 and p = 0.004). Ferritin levels were 5306 ± 1506 ng/mL in Group 1 and 2020 ± 1205 ng/mL in Group 2, and the difference was significant (p = 0.001). Group 1 had significantly lower Ca and P levels (p < 0.001, p = 0.038). BMD was negatively correlated with ferritin (r = −0.791, p < 0.001) and positively correlated with calcium (r = 0.499, p = 0.008). Conclusions: Osteoporosis is a common condition in TM patients. Patients with risk factors should be followed more closely. These patients should be identified before BMD decreases. To prevent osteoporosis, regular BMD scans should be performed, calcium and vitamin D supplementation should be provided, and physical activity should be encouraged.
- 26 February 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1579
Open AccessEvaluation of Children and Adolescents with Thalassemia Major in Terms of Osteoporosis: A Single-Centre Experience
Background/Objectives: This study aimed to determine the frequency of osteoporosis in children and adolescents with thalassemia major (TM) and to identify risk factors for the early development of osteoporosis. Methods: This retrospective study included 27 patients under 18 years of age receiving regular blood transfusions and chelation therapy for TM at our hospital. Bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry, and a lumbar spine Z-score <−2 was considered osteoporotic. Patients with osteoporosis were classified as Group 1 and those without osteoporosis as Group 2. Results: Osteoporosis was detected in 22.2% of the study population. The mean age was 13.83 ± 2.85 years in Group 1 and 7.95 ± 5.05 years in Group 2 (p = 0.012). Body weight and height were significantly lower in Group 1 (p = 0.012 and p = 0.004). Ferritin levels were 5306 ± 1506 ng/mL in Group 1 and 2020 ± 1205 ng/mL in Group 2, and the difference was significant (p = 0.001). Group 1 had significantly lower Ca and P levels (p < 0.001, p = 0.038). BMD was negatively correlated with ferritin (r = −0.791, p < 0.001) and positively correlated with calcium (r = 0.499, p = 0.008). Conclusions: Osteoporosis is a common condition in TM patients. Patients with risk factors should be followed more closely. These patients should be identified before BMD decreases. To prevent osteoporosis, regular BMD scans should be performed, calcium and vitamin D supplementation should be provided, and physical activity should be encouraged.
- Open Access
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (3) , 498-506
Types and clinical features of 140 newly diagnosed cases of diabetes in childhood: a single-center experience
Purpose: Type 1 diabetes (T1DM) accounts for the majority of childhood diabetes mellitus (DM). However, in recent years, there has been an increase in the prevalence of type 2 diabetes mellitus (T2DM) and the diagnosis of monogenic diabetes (MD). The aim of this study was to evaluate the clinical and laboratory findings, as well as the types of DM, in patients diagnosed between the ages of 0 and 18. Materials and methods: In the study, 140 patients diagnosed with DM in our clinic were evaluated retrospectively. Results: During the 3-year period, 140 patients (n=76, 54.3% male) were diagnosed with diabetes. The mean age at diagnosis of the patients was 10±4.19 years. 93.6% of patients were diagnosed with T1DM, 2.8% of patients with T2DM and 3.6% of patients were diagnosed with MD. It was observed that the cases of T1DM peaked in the 5-9 (36.6%) and 10-14 (37.4%) age groups. the prevalence of diabetic ketoacidosis (DKA) was 61.8%. The majority of patients 64.9% with T1DM were diagnosed in the autumn/winter months. 75% of the patients with T2DM were female, and the mean age at diagnosis was 15.05±1.11years. Two of the cases of MD were neonatal DM, two were GCK-MODY and one was CEL-MODY. Conclusion: Although the majority of childhood diabetes cases are T1DM, the frequency of T2DM tends to increase, especially in obese adolescents. It should be kept in mind that obesity may also occur in autoantibody-positive T1DM patients. It was determined that T1DM cases were more common in the winter season, in the 10-14 age group, and that DKA was higher. Genetic examination should be performed in cases with suspected MD.
- 1 January 2025
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (3) , 498-506
Open AccessTypes and clinical features of 140 newly diagnosed cases of diabetes in childhood: a single-center experience
Purpose: Type 1 diabetes (T1DM) accounts for the majority of childhood diabetes mellitus (DM). However, in recent years, there has been an increase in the prevalence of type 2 diabetes mellitus (T2DM) and the diagnosis of monogenic diabetes (MD). The aim of this study was to evaluate the clinical and laboratory findings, as well as the types of DM, in patients diagnosed between the ages of 0 and 18. Materials and methods: In the study, 140 patients diagnosed with DM in our clinic were evaluated retrospectively. Results: During the 3-year period, 140 patients (n=76, 54.3% male) were diagnosed with diabetes. The mean age at diagnosis of the patients was 10±4.19 years. 93.6% of patients were diagnosed with T1DM, 2.8% of patients with T2DM and 3.6% of patients were diagnosed with MD. It was observed that the cases of T1DM peaked in the 5-9 (36.6%) and 10-14 (37.4%) age groups. the prevalence of diabetic ketoacidosis (DKA) was 61.8%. The majority of patients 64.9% with T1DM were diagnosed in the autumn/winter months. 75% of the patients with T2DM were female, and the mean age at diagnosis was 15.05±1.11years. Two of the cases of MD were neonatal DM, two were GCK-MODY and one was CEL-MODY. Conclusion: Although the majority of childhood diabetes cases are T1DM, the frequency of T2DM tends to increase, especially in obese adolescents. It should be kept in mind that obesity may also occur in autoantibody-positive T1DM patients. It was determined that T1DM cases were more common in the winter season, in the 10-14 age group, and that DKA was higher. Genetic examination should be performed in cases with suspected MD.
- Open Access
- 22 December 2024
- Published by Zeus Publishing in Journal of Medical and Dental Investigations
- Vol. 5
Chronic respiratory failure after the first dose of nusinersen treatment: A case report
Spinal muscular atrophy (SMA) is a disease characterized by progressive nerve cell loss in the spinal cord and brainstem. It can be fatal if left untreated, particularly in infantile forms. Nusinersen became the first disease-modifying agent to be approved in 2016 for the treatment of all types of 5q-associated SMA, across all age groups. Trials have shown that the drug has an acceptable safety profile and has significantly improved clinical care for patients; however, data on long-term risks and benefits are limited. Respiratory problems following use of the drug are an important potential complication and the mechanisms of action are not fully understood. This study reports on a patient with type 1 SMA who developed chronic respiratory failure after the first dose of nusinersen, a condition not previously reported. Although nusinersen significantly improves patients' quality of life, its long-term or rare side effects are not well understood. Patients should be closely monitored for respiratory side effects, especially after the first dose, and families should be thoroughly informed about potential respiratory complications. How to cite this article: Orhan Ö, Talay MN, Büyükşahin HN, Demirbuğa A, Özbek MN, Özgün N. A case of chronic respiratory failure after the first dose of nusinersen treatment. J Med Dent Invest. 2024; 5: e240341.
- 22 December 2024
- Published by Zeus Publishing in Journal of Medical and Dental Investigations
- Vol. 5
Open AccessChronic respiratory failure after the first dose of nusinersen treatment: A case report
Spinal muscular atrophy (SMA) is a disease characterized by progressive nerve cell loss in the spinal cord and brainstem. It can be fatal if left untreated, particularly in infantile forms. Nusinersen became the first disease-modifying agent to be approved in 2016 for the treatment of all types of 5q-associated SMA, across all age groups. Trials have shown that the drug has an acceptable safety profile and has significantly improved clinical care for patients; however, data on long-term risks and benefits are limited. Respiratory problems following use of the drug are an important potential complication and the mechanisms of action are not fully understood. This study reports on a patient with type 1 SMA who developed chronic respiratory failure after the first dose of nusinersen, a condition not previously reported. Although nusinersen significantly improves patients' quality of life, its long-term or rare side effects are not well understood. Patients should be closely monitored for respiratory side effects, especially after the first dose, and families should be thoroughly informed about potential respiratory complications. How to cite this article: Orhan Ö, Talay MN, Büyükşahin HN, Demirbuğa A, Özbek MN, Özgün N. A case of chronic respiratory failure after the first dose of nusinersen treatment. J Med Dent Invest. 2024; 5: e240341.
- Open Access
- 2 July 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (1) , 17-25
Inequalities in Access to Diabetes Technologies in Children with Type 1 Diabetes: A Multicenter, Cross-sectional Study from Türkiye
To determine inequalities in access to diabetes technologies and the effect of socioeconomic factors on families with children with type 1 diabetes. In this multicenter cross-sectional study, parents of children with type 1 diabetes completed a questionnaire about household sociodemographic characteristics, latest HbA1c values, continuous glucose monitoring (CGM) and insulin pump use of children, the education and working status of parents. These characteristics were compared between technology use (only-CGM, only-pump, CGM+pump, no technology use). Among 882 families, only-CGM users, only-pump users, and CGM+pump users compared with no technology users, adjusting for age, sex, region, education levels, number of working parents, and household income. Children living in the least developed region had lower odds of having only-CGM (OR=0.20, 95%CI 0.12-0.34) and having CGM+pump (OR=0.07, 95%CI 0.03-0.22) compared with those living in the most developed region. Children with parents who had not finished high school had lower odds of having only-CGM (Mothers: OR=0.36, 95%CI 0.19-0.66; fathers: OR=0.32, 95%CI 0.18-0.60) or both CGM+pump (OR=0.27, 95%CI 0.11-0.64; fathers: OR=0.34, 95%CI 0.15-0.79) rather than no-technology compared to children whose parents has a university degree. Every $840 increase in the household income increased the odds by 5% for having only-CGM (OR=1.05, 95%CI 1.02-1.09) and CGM+pump (OR=1.05, 95%CI 1.01-1.08). Socioeconomic factors such as education, regions, and income were associated with inequality in access to technologies. The inequalities are more prominent in access to CGM while CGM had a bigger contribution to glycemic control.
- 2 July 2024
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (1) , 17-25
Open AccessInequalities in Access to Diabetes Technologies in Children with Type 1 Diabetes: A Multicenter, Cross-sectional Study from Türkiye
To determine inequalities in access to diabetes technologies and the effect of socioeconomic factors on families with children with type 1 diabetes. In this multicenter cross-sectional study, parents of children with type 1 diabetes completed a questionnaire about household sociodemographic characteristics, latest HbA1c values, continuous glucose monitoring (CGM) and insulin pump use of children, the education and working status of parents. These characteristics were compared between technology use (only-CGM, only-pump, CGM+pump, no technology use). Among 882 families, only-CGM users, only-pump users, and CGM+pump users compared with no technology users, adjusting for age, sex, region, education levels, number of working parents, and household income. Children living in the least developed region had lower odds of having only-CGM (OR=0.20, 95%CI 0.12-0.34) and having CGM+pump (OR=0.07, 95%CI 0.03-0.22) compared with those living in the most developed region. Children with parents who had not finished high school had lower odds of having only-CGM (Mothers: OR=0.36, 95%CI 0.19-0.66; fathers: OR=0.32, 95%CI 0.18-0.60) or both CGM+pump (OR=0.27, 95%CI 0.11-0.64; fathers: OR=0.34, 95%CI 0.15-0.79) rather than no-technology compared to children whose parents has a university degree. Every $840 increase in the household income increased the odds by 5% for having only-CGM (OR=1.05, 95%CI 1.02-1.09) and CGM+pump (OR=1.05, 95%CI 1.01-1.08). Socioeconomic factors such as education, regions, and income were associated with inequality in access to technologies. The inequalities are more prominent in access to CGM while CGM had a bigger contribution to glycemic control.
- Open Access
- 12 June 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (3) , 508-516
Evaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit
Background/aim: Therapeutic plasma exchange (TPE) is an extracorporeal treatment method that removes large molecular weight substances from plasma. In our study, we aimed to retrospectively examine the indications and procedural methods of the patients who had undergone TPE, and the complications that occurred during the procedure. Materials and methods: Forty-one patients who were monitored in thePICU of Gazi Yaşargil Training and Research Hospital and had indications for TPE between 2017 and 2021 were included in the study. Laboratory parameters were checked before and after the TPE procedure. In addition to these, patients’ diagnosis, weight, type of procedure and type of device, where the procedure was performed, duration of the procedure, amount of blood and plasma processed, complications, number of procedures, and death during the procedure or independent of the procedure were evaluated. Results: The median age was 93.0 (14.0–167.0) months. Hemolytic uremic syndrome (HUS) was the most common TPE indication with nine patients. The most common complication related to TPE was fever (11 patients), while no complication was observed in 18 patients. When laboratory results were evaluated according to American Society for Apheresis (ASFA) categories, a significant improvement was observed in the values of platelet, AST, ALT, LDH, urea, and creatinine in ASFA1 after TPE. No significant improvement was observed in ASFA2 (p > 0.05). In ASFA3, a significant improvement was observed in INR, AST, ALT, LDH, total bilirubin, creatinine, pH, and lactate values after TPE (p < 0.05). Five patients died from ASFA1, one from ASFA2, and three patients from ASFA3. Conclusion: Since significant adjustments are observed in clinical and laboratory values in sepsis-MOF, which is in the ASFA3 category, we believe that it should be evaluated in the ASFA2 or ASFA1 category in the early treatment of these diseases. In addition, we think that MIS-C cases, which have not been in any category according to ASFA, should be included in the ASFA2 or ASFA3 category, considering our TPE results.
- 12 June 2024
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 54 (3) , 508-516
Open AccessEvaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit
Background/aim: Therapeutic plasma exchange (TPE) is an extracorporeal treatment method that removes large molecular weight substances from plasma. In our study, we aimed to retrospectively examine the indications and procedural methods of the patients who had undergone TPE, and the complications that occurred during the procedure. Materials and methods: Forty-one patients who were monitored in thePICU of Gazi Yaşargil Training and Research Hospital and had indications for TPE between 2017 and 2021 were included in the study. Laboratory parameters were checked before and after the TPE procedure. In addition to these, patients’ diagnosis, weight, type of procedure and type of device, where the procedure was performed, duration of the procedure, amount of blood and plasma processed, complications, number of procedures, and death during the procedure or independent of the procedure were evaluated. Results: The median age was 93.0 (14.0–167.0) months. Hemolytic uremic syndrome (HUS) was the most common TPE indication with nine patients. The most common complication related to TPE was fever (11 patients), while no complication was observed in 18 patients. When laboratory results were evaluated according to American Society for Apheresis (ASFA) categories, a significant improvement was observed in the values of platelet, AST, ALT, LDH, urea, and creatinine in ASFA1 after TPE. No significant improvement was observed in ASFA2 (p > 0.05). In ASFA3, a significant improvement was observed in INR, AST, ALT, LDH, total bilirubin, creatinine, pH, and lactate values after TPE (p < 0.05). Five patients died from ASFA1, one from ASFA2, and three patients from ASFA3. Conclusion: Since significant adjustments are observed in clinical and laboratory values in sepsis-MOF, which is in the ASFA3 category, we believe that it should be evaluated in the ASFA2 or ASFA1 category in the early treatment of these diseases. In addition, we think that MIS-C cases, which have not been in any category according to ASFA, should be included in the ASFA2 or ASFA3 category, considering our TPE results.
- Open Access
- 15 January 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (1)
Our Treatment Experience in Poisoning With Calcium Channel Blockers: A Series of Twelve Cases
Background: Intoxications with cardiovascular system drugs constitute a small percentage of all poisoning cases. Calcium Channel Blockers (CCBs) are the most common drug poisoning in this group. Objectives: We aimed to evaluate the effectiveness of treatments for CCB poisoning and add to the current body of literature by outlining the clinical treatments we employ for bradyarrhythmia, hypotension, and resistant vasodilation resulting from CCB poisoning, as well as sharing our clinical insights in this field. Methods: Twelve patients, ranging in age from 1 month to 18 years, were admitted to the Tertiary Paediatric Intensive Care Unit (PICU) for treatment of medication poisoning related to the CCB group. Patients who ingested several drugs that caused CCB were not allowed to participate in the trial. Results: Twelve patients were followed up in the PICU due to poisoning with CCB group drugs. Of the patients, 7 were male and 5 were female. Five of the patients had taken CCB medication with the purpose of committing suicide, and 7 of them accidentally. All of the patients who received CCB to commit suicide had taken verapamil. Five patients whose hypotension and bradycardia continued were administered inotropes. In addition to PI, calcium gluconate, intravenous lipid, glucagon, insulin, bicarbonate, and methylene blue were given as therapy to our symptomatic patients. Plasmapheresis was applied to a patient who was hospitalized in the PICU due to a sudden loss of consciousness. Conclusions: In the management of patients with CCB poisoning, the use of hyperinsulinemia euglycemia, intravenous lipid emulsion treatment, glucagon treatments, and treatments including methylene blue and extracorporeal life support should be considered in cases of resistant hypotension, bradycardia, and coma in the early period.
- 15 January 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (1)
Open AccessOur Treatment Experience in Poisoning With Calcium Channel Blockers: A Series of Twelve Cases
Background: Intoxications with cardiovascular system drugs constitute a small percentage of all poisoning cases. Calcium Channel Blockers (CCBs) are the most common drug poisoning in this group. Objectives: We aimed to evaluate the effectiveness of treatments for CCB poisoning and add to the current body of literature by outlining the clinical treatments we employ for bradyarrhythmia, hypotension, and resistant vasodilation resulting from CCB poisoning, as well as sharing our clinical insights in this field. Methods: Twelve patients, ranging in age from 1 month to 18 years, were admitted to the Tertiary Paediatric Intensive Care Unit (PICU) for treatment of medication poisoning related to the CCB group. Patients who ingested several drugs that caused CCB were not allowed to participate in the trial. Results: Twelve patients were followed up in the PICU due to poisoning with CCB group drugs. Of the patients, 7 were male and 5 were female. Five of the patients had taken CCB medication with the purpose of committing suicide, and 7 of them accidentally. All of the patients who received CCB to commit suicide had taken verapamil. Five patients whose hypotension and bradycardia continued were administered inotropes. In addition to PI, calcium gluconate, intravenous lipid, glucagon, insulin, bicarbonate, and methylene blue were given as therapy to our symptomatic patients. Plasmapheresis was applied to a patient who was hospitalized in the PICU due to a sudden loss of consciousness. Conclusions: In the management of patients with CCB poisoning, the use of hyperinsulinemia euglycemia, intravenous lipid emulsion treatment, glucagon treatments, and treatments including methylene blue and extracorporeal life support should be considered in cases of resistant hypotension, bradycardia, and coma in the early period.
- Open Access
- 22 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (51) , e36778
Evaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011–2019 in Diyarbakir, Turkey
This study aimed to determine the incidence of congenital hypothyroidism in Turkey’s Diyarbakir Province and assess the development and growth conditions of people with congenital hypothyroidism. Patients born between 2011-2019 and diagnosed with congenital hypothyroidism within the scope of the newborn screening program were included. The medical records of these patients were retrospectively reviewed. The length and weight for age, weight for length, and body mass index standard deviation scores were calculated. We investigated the treatment status of the patients, whether their relatives had a similar disorder, and the presence of consanguinity between parents. Blood samples were collected from 380,592 newborns. As a result of further tests, 498 newborns were diagnosed with congenital hypothyroidism (incidence: 1/764). Demographic and anthropometric data of 241 patients were analyzed. The patients comprised 46.9% (n = 113) females and 53.1% (n = 128) males. It was determined that 44.4% of the individuals had transient congenital hypothyroidism and 53.6% had permanent congenital hypothyroidism. The parents of 29.8% of the individuals diagnosed with transient congenital hypothyroidism and 44.2% of the individuals diagnosed with permanent congenital hypothyroidism were consanguineous (P = .02). According to the latest anthropometric assessment, 6.8% of individuals diagnosed with congenital hypothyroidism had a weight z-score below −2 SD and 16.9% had a length z-score below −2 SD. The incidence of congenital hypothyroidism was higher in our region. The ratio of consanguinity between parents was higher in patients diagnosed with permanent congenital hypothyroidism than in those diagnosed with transient congenital hypothyroidism. According to the most recent follow-up, weight and age were found to be similar in patients with transient and permanent congenital hypothyroidism.
- 22 December 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (51) , e36778
Open AccessEvaluation of patients diagnosed with congenital hypothyroidism by newborn screening between 2011–2019 in Diyarbakir, Turkey
This study aimed to determine the incidence of congenital hypothyroidism in Turkey’s Diyarbakir Province and assess the development and growth conditions of people with congenital hypothyroidism. Patients born between 2011-2019 and diagnosed with congenital hypothyroidism within the scope of the newborn screening program were included. The medical records of these patients were retrospectively reviewed. The length and weight for age, weight for length, and body mass index standard deviation scores were calculated. We investigated the treatment status of the patients, whether their relatives had a similar disorder, and the presence of consanguinity between parents. Blood samples were collected from 380,592 newborns. As a result of further tests, 498 newborns were diagnosed with congenital hypothyroidism (incidence: 1/764). Demographic and anthropometric data of 241 patients were analyzed. The patients comprised 46.9% (n = 113) females and 53.1% (n = 128) males. It was determined that 44.4% of the individuals had transient congenital hypothyroidism and 53.6% had permanent congenital hypothyroidism. The parents of 29.8% of the individuals diagnosed with transient congenital hypothyroidism and 44.2% of the individuals diagnosed with permanent congenital hypothyroidism were consanguineous (P = .02). According to the latest anthropometric assessment, 6.8% of individuals diagnosed with congenital hypothyroidism had a weight z-score below −2 SD and 16.9% had a length z-score below −2 SD. The incidence of congenital hypothyroidism was higher in our region. The ratio of consanguinity between parents was higher in patients diagnosed with permanent congenital hypothyroidism than in those diagnosed with transient congenital hypothyroidism. According to the most recent follow-up, weight and age were found to be similar in patients with transient and permanent congenital hypothyroidism.